Skip to main content
Top
Published in: Clinical Rheumatology 7/2013

01-07-2013 | Original Article

Functional evaluation of the joints in acromegalic patients and associated factors

Authors: Leandro Lemgruber Kropf, Miguel Madeira, Leonardo Vieira Neto, Mônica Roberto Gadelha, Maria Lucia Fleiuss de Farias

Published in: Clinical Rheumatology | Issue 7/2013

Login to get access

Abstract

This study aims to evaluate the presence of arthropathy in the large peripheral joints most commonly affected in acromegaly and to classify the severity according to the functional assessment of each joint to identify any factor that could predict the development of arthropathy and its level of severity. Seventy-one acromegalic patients were interviewed and underwent a physical examination of the knees, hips, and shoulders to identify the presence of arthropathy. The disease was functionally classified as more severe or less severe, according to a specific functional scale. We studied 21 males (29.5 %) and 50 females (70.5 %) with a mean age of 49.5 ± 14.5 years. Arthropathy in the studied joints was observed in 40 patients (prevalence of 56 %), and a statistically significant association with the presence of arthropathy was observed for three of the evaluated factors: increased body mass index (BMI), older age at diagnosis of acromegaly, and female gender. There was no association with disease control or other factors related to acromegaly. We classified 19 patients as having more functionally severe arthropathy and identified two factors associated with its development: increased BMI and lower levels of insulin-like growth factor type I. The relationship of factors such as female sex and BMI, which are also related to osteoarthritis, with arthropathy in acromegalic patients suggested a high prevalence of irreversible joint disease present at diagnosis of acromegaly. We highlight the BMI, which was associated with either the presence of arthropathy or more severe arthropathy, which demonstrates the importance of body weight control in the management of acromegalic patients.
Literature
1.
go back to reference Marie P (1886) On two cases of acromegaly: marked hypertrophy of the upper and lower limbs and head. Rev Med 6:297–333 Marie P (1886) On two cases of acromegaly: marked hypertrophy of the upper and lower limbs and head. Rev Med 6:297–333
2.
go back to reference Shlomo AB, Melmed S (2008) Acromegaly. Endocrinol Metabol Clin N Am 37:101–122CrossRef Shlomo AB, Melmed S (2008) Acromegaly. Endocrinol Metabol Clin N Am 37:101–122CrossRef
4.
go back to reference Detenbeck LC, Tressler HA, O’Duffy JD, Randall RV (1973) Peripheral joint manifestations of acromegaly. Clin Orthop 91:119–127PubMedCrossRef Detenbeck LC, Tressler HA, O’Duffy JD, Randall RV (1973) Peripheral joint manifestations of acromegaly. Clin Orthop 91:119–127PubMedCrossRef
5.
go back to reference Colao A, Pivonello R, Scarpa R, Vallone G, Ruosi C, Lombardi G (2005) The acromegalic arthropathy. J Endocrinol Invest 28(Suppl 8):24–31PubMed Colao A, Pivonello R, Scarpa R, Vallone G, Ruosi C, Lombardi G (2005) The acromegalic arthropathy. J Endocrinol Invest 28(Suppl 8):24–31PubMed
6.
go back to reference Colao A, Marzullo P, Vallone G, Marino V, Annecchino M, Ferone D et al (1998) Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 83:2121–2125PubMedCrossRef Colao A, Marzullo P, Vallone G, Marino V, Annecchino M, Ferone D et al (1998) Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 83:2121–2125PubMedCrossRef
7.
go back to reference Podgorski M, Robinson B, Weissberger A, Stiel J, Wang S, Brooks PM (1988) Articular manifestations of acromegaly. Aust N Z J Med 18:28–35PubMedCrossRef Podgorski M, Robinson B, Weissberger A, Stiel J, Wang S, Brooks PM (1988) Articular manifestations of acromegaly. Aust N Z J Med 18:28–35PubMedCrossRef
8.
go back to reference Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P (1988) Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clin Endocrinol 28:515–524CrossRef Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P (1988) Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clin Endocrinol 28:515–524CrossRef
9.
go back to reference Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH (1988) Acromegalic arthropathy. Characteristics and response to therapy. Arthritis Rheum 31:1022–1027PubMedCrossRef Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH (1988) Acromegalic arthropathy. Characteristics and response to therapy. Arthritis Rheum 31:1022–1027PubMedCrossRef
10.
go back to reference Barkan A (1997) Acromegalic arthropathy and sleep apnea. J Endocrinol 155(Suppl 9):41–44 Barkan A (1997) Acromegalic arthropathy and sleep apnea. J Endocrinol 155(Suppl 9):41–44
11.
go back to reference Lieberman SA, Bjorkengren AG, Hoffman AR (1992) Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am 21:615–631PubMed Lieberman SA, Bjorkengren AG, Hoffman AR (1992) Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am 21:615–631PubMed
12.
go back to reference Forgacs SS (1998) Acromegaly. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London Forgacs SS (1998) Acromegaly. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London
13.
go back to reference Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW et al (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376PubMedCrossRef Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW et al (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376PubMedCrossRef
14.
go back to reference Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90:2731–2739PubMedCrossRef Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90:2731–2739PubMedCrossRef
15.
go back to reference Chipman JJ, Attanasio AF, Birkett MA, Bates PC, Webb S, Lamberts SW (1997) The safety profile of GH replacement therapy in adults. Clin Endocrinol 46:473–481CrossRef Chipman JJ, Attanasio AF, Birkett MA, Bates PC, Webb S, Lamberts SW (1997) The safety profile of GH replacement therapy in adults. Clin Endocrinol 46:473–481CrossRef
16.
go back to reference Bluestone R, Bywaters EG, Hartog M, Holt PJ, Hyde S (1997) Acromegalic arthropathy. Ann Rheum Dis 30:243–258CrossRef Bluestone R, Bywaters EG, Hartog M, Holt PJ, Hyde S (1997) Acromegalic arthropathy. Ann Rheum Dis 30:243–258CrossRef
17.
go back to reference Scarpa R, De Brasi D, Pivonello R, Marzullo P, Manguso F, Sodano A et al (2004) Acromegalic axial arthropathy: a clinical case–control study. J Clin Endocrinol Metab 89:598–603PubMedCrossRef Scarpa R, De Brasi D, Pivonello R, Marzullo P, Manguso F, Sodano A et al (2004) Acromegalic axial arthropathy: a clinical case–control study. J Clin Endocrinol Metab 89:598–603PubMedCrossRef
18.
go back to reference Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526–529PubMedCrossRef Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526–529PubMedCrossRef
19.
go back to reference Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148PubMedCrossRef Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148PubMedCrossRef
20.
go back to reference D’Aubigné RM, Postel M (1954) Functional results of hip arthroplasty with acrylic prosthesis. J Bone Jt Surg Am 36-A(Suppl 3):451–475 D’Aubigné RM, Postel M (1954) Functional results of hip arthroplasty with acrylic prosthesis. J Bone Jt Surg Am 36-A(Suppl 3):451–475
21.
go back to reference Charnley J (1972) The long-term results of low friction arthroplasty of the hip performed as a primary intervention. J Bone Jt Surg Am 54-B:61–76 Charnley J (1972) The long-term results of low friction arthroplasty of the hip performed as a primary intervention. J Bone Jt Surg Am 54-B:61–76
22.
go back to reference Insall JN, Dorr LD, Scott RD, Scott WN (1989) Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 248:13–14PubMed Insall JN, Dorr LD, Scott RD, Scott WN (1989) Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 248:13–14PubMed
23.
go back to reference Asif S, Choon DS (2005) Midterm results of cemented press fit condylar sigma total knee arthroplasty system. J Orthop Surg (Hong Kong) 13:280–284 Asif S, Choon DS (2005) Midterm results of cemented press fit condylar sigma total knee arthroplasty system. J Orthop Surg (Hong Kong) 13:280–284
24.
go back to reference Amstutz HC, Sew Hoy AL, Clarke IC (1981) UCLA anatomic total shoulder arthroplasty. Clin Orthop Relat Res 155:7–20PubMed Amstutz HC, Sew Hoy AL, Clarke IC (1981) UCLA anatomic total shoulder arthroplasty. Clin Orthop Relat Res 155:7–20PubMed
25.
go back to reference Nutton RW, McBirnie JM, Phillips C (1997) Treatment of chronic rotator-cuff impingement by arthroscopic subacromial decompression. J Bone Joint Surg Br 79:73–76PubMedCrossRef Nutton RW, McBirnie JM, Phillips C (1997) Treatment of chronic rotator-cuff impingement by arthroscopic subacromial decompression. J Bone Joint Surg Br 79:73–76PubMedCrossRef
26.
go back to reference Elmlinger MW, Kühnel W, Weber MM, Ranke MB (2004) Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP3). Clin Chem Lab Med 42:654–664PubMedCrossRef Elmlinger MW, Kühnel W, Weber MM, Ranke MB (2004) Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP3). Clin Chem Lab Med 42:654–664PubMedCrossRef
27.
go back to reference Fellet A, Fellet AJ, Fellet L (2007) [Osteoarthritis: a review]. Rev Bras Med 64:55–61, Portuguese Fellet A, Fellet AJ, Fellet L (2007) [Osteoarthritis: a review]. Rev Bras Med 64:55–61, Portuguese
28.
go back to reference Biermasz NR, Wassenaar MJ, van der Klaauw AA (2009) Pretreatment insulin-like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease. J Clin Endocrinol Metab 94(7):2374–2379PubMedCrossRef Biermasz NR, Wassenaar MJ, van der Klaauw AA (2009) Pretreatment insulin-like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease. J Clin Endocrinol Metab 94(7):2374–2379PubMedCrossRef
29.
go back to reference Giorgi RDN (2005) [Osteoarthritis in clinical practice]. Temas Reumatol Clín 6:17–30, Portuguese Giorgi RDN (2005) [Osteoarthritis in clinical practice]. Temas Reumatol Clín 6:17–30, Portuguese
30.
go back to reference Spector TD, Nandra D, Hart DJ, Doyle DV (1997) Is hormone replacement protective for hand and knee osteoarthritis in women? The Chingford study. Ann Rheum Dis 56(7):432–434PubMedCrossRef Spector TD, Nandra D, Hart DJ, Doyle DV (1997) Is hormone replacement protective for hand and knee osteoarthritis in women? The Chingford study. Ann Rheum Dis 56(7):432–434PubMedCrossRef
31.
go back to reference Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Parazzini F, Zaninelli A et al (2005) Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum 35(Suppl 1):17–23PubMedCrossRef Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Parazzini F, Zaninelli A et al (2005) Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum 35(Suppl 1):17–23PubMedCrossRef
32.
go back to reference Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM (2005) Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65(2):312–315PubMedCrossRef Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM (2005) Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65(2):312–315PubMedCrossRef
33.
go back to reference Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonça LM, Gadelha MR et al (2010) Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly. Osteoporos Int 21(12):2019–2025PubMedCrossRef Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonça LM, Gadelha MR et al (2010) Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly. Osteoporos Int 21(12):2019–2025PubMedCrossRef
34.
go back to reference Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ (2007) Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89-B:672–685CrossRef Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ (2007) Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89-B:672–685CrossRef
35.
go back to reference Fortier LA, Mohammed HO, Lust G, Nixon AJ (2002) Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 84-B:276–288CrossRef Fortier LA, Mohammed HO, Lust G, Nixon AJ (2002) Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 84-B:276–288CrossRef
36.
go back to reference Miller RE, Grodzinsky AJ, Cummings K, Plaas AH, Cole AA, Lee RT et al (2010) Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum 62(12):3686–3694PubMedCrossRef Miller RE, Grodzinsky AJ, Cummings K, Plaas AH, Cole AA, Lee RT et al (2010) Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum 62(12):3686–3694PubMedCrossRef
37.
go back to reference Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K et al (2005) Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 12:1171–1179PubMedCrossRef Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K et al (2005) Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 12:1171–1179PubMedCrossRef
38.
go back to reference Wassenaar MJ, Biermasz NR, Bijsterbosch J, Pereira AM, Meulenbelt I, Smit JW et al (2011) Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann Rheum Dis 70(2):320–325PubMedCrossRef Wassenaar MJ, Biermasz NR, Bijsterbosch J, Pereira AM, Meulenbelt I, Smit JW et al (2011) Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann Rheum Dis 70(2):320–325PubMedCrossRef
39.
go back to reference Rosis RG, Massabki PS, Kairalla M (2010) [Osteoarthritis: clinical and epidemiological assessment of elderly patients in long-term institution]. Rev Bras Clin Med 8(2):101–108, Portuguese Rosis RG, Massabki PS, Kairalla M (2010) [Osteoarthritis: clinical and epidemiological assessment of elderly patients in long-term institution]. Rev Bras Clin Med 8(2):101–108, Portuguese
40.
go back to reference Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81(9):646–656PubMed Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81(9):646–656PubMed
41.
go back to reference East HE, Subauste JS, Gandhi A, Koch CA (2012) About secondary causes of diabetes mellitus. J Miss State Med Assoc 53(11):380–383PubMed East HE, Subauste JS, Gandhi A, Koch CA (2012) About secondary causes of diabetes mellitus. J Miss State Med Assoc 53(11):380–383PubMed
42.
go back to reference Wiesner TD, Trantakis C, Meixensberger J, Koch CA, Zimmer C, Paschke R (2005) Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and the results for treatment of prolactin and growth hormone secreting pituitary tumors. Med Klin 100(4):173–179CrossRef Wiesner TD, Trantakis C, Meixensberger J, Koch CA, Zimmer C, Paschke R (2005) Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and the results for treatment of prolactin and growth hormone secreting pituitary tumors. Med Klin 100(4):173–179CrossRef
43.
go back to reference Watson JC, Stratatkis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, Carney JA, Oldfield EH (2000) Neurosurgical implications of Carney complex. J Neurosurg 92(3):413–418PubMedCrossRef Watson JC, Stratatkis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, Carney JA, Oldfield EH (2000) Neurosurgical implications of Carney complex. J Neurosurg 92(3):413–418PubMedCrossRef
Metadata
Title
Functional evaluation of the joints in acromegalic patients and associated factors
Authors
Leandro Lemgruber Kropf
Miguel Madeira
Leonardo Vieira Neto
Mônica Roberto Gadelha
Maria Lucia Fleiuss de Farias
Publication date
01-07-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2219-1

Other articles of this Issue 7/2013

Clinical Rheumatology 7/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.